Cannvas Engages Catapult Growth Partners to Explore Transactions Within Global Cannabis Sector

Cannvas MedTech (CSE:MTEC) (Frankfurt:3CM) (OTC:CANVF), a leading digital cannabis education and analytics company, is pleased to announce it has engaged Catapult Growth Partners (“Catapult”), a leading North American-based consultancy firm focused on helping businesses accelerate profitable growth and increase equity value, to explore transactions within the global cannabis sector to maximize shareholder value.

“Catapult Growth Partners excels in supporting businesses like Cannvas develop and expand into leading international organizations and we’re excited to begin this journey with their capable team to explore all the opportunities available to us across the world,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech. “Everything is open for discussion as we continue to work toward growing Cannvas into an international leader in unbiased cannabis education and deep cannabis data, and we look forward to the new and exciting ventures this partnership may offer.”

Cannvas will work with Catapult to help accelerate profitable growth through a review of the Company’s strategic development and support for practical execution. Using Catapult’s vast network of international organizations, Cannvas will also tap into talent acquisition and management resources. The goal of the partnership is to ultimately position Cannvas to maximize value for its shareholders through transactions, including mergers and acquisitions, within the global cannabis and technology sectors.

The companies will implement a strategic review of all Cannvas properties to gain clearer insight into all available options to maximize the value of the Company. Presently there is no definite schedule to complete the evaluation process and there are no assurances or guarantees the evaluation will result in a transaction.

Since its founding in 2004, Catapult Growth Partners has developed an outstanding track record enabling firms to grow and position for a successful exit. A leading North American-based investment bank and consultancy focused on helping businesses accelerate profitable growth and increase equity value, Catapult specializes in a variety of sectors such as health tech, artificial intelligence and technology services.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering
accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

Renseignements: ir@cannvasmedtech.com or visit cannvas.com

Related Links

https://cannvasmedtech.com

Click here to connect with Cannvas MedTech (CSE:MTEC) (Frankfurt:3CM) (OTC:CANVF) for an Investor Presentation.